Indegene Limited (BOM:544172)
India · Delayed Price · Currency is INR 509.25
-0.75 (-0.15%)
At close: Jul 20, 2026
Indegene Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 35,105 | 28,393 | 25,896 | 23,061 | 16,646 |
| 35,105 | 28,393 | 25,896 | 23,061 | 16,646 | |
Revenue Growth (YoY) | 23.64% | 9.64% | 12.29% | 38.54% | 69.76% |
Cost of Revenue | 778 | 624 | 588 | 412 | 324.59 |
Gross Profit | 34,327 | 27,769 | 25,308 | 22,649 | 16,322 |
Selling, General & Admin | 22,044 | 18,200 | 16,560 | 14,688 | 10,216 |
Other Operating Expenses | 6,041 | 4,226 | 3,640 | 4,000 | 3,231 |
Operating Expenses | 29,357 | 23,228 | 20,961 | 19,286 | 13,787 |
Operating Income | 4,970 | 4,541 | 4,347 | 3,363 | 2,535 |
Interest Expense | -160 | -194 | -463 | -233 | -46.7 |
Interest & Investment Income | 363 | 501 | 296 | 103 | 8.03 |
Currency Exchange Gain (Loss) | -22 | 95 | 162 | 398 | 189.74 |
Other Non Operating Income (Expenses) | -8 | -4 | -5 | -70 | -1.96 |
EBT Excluding Unusual Items | 5,143 | 4,939 | 4,337 | 3,561 | 2,684 |
Impairment of Goodwill | - | - | -911 | - | - |
Gain (Loss) on Sale of Investments | 300 | 292 | 165 | 69 | 50.14 |
Gain (Loss) on Sale of Assets | 1 | - | - | - | - |
Legal Settlements | -203 | - | - | - | - |
Other Unusual Items | 9 | 162 | 995 | - | -468.99 |
Pretax Income | 5,250 | 5,393 | 4,586 | 3,630 | 2,265 |
Income Tax Expense | 1,239 | 1,326 | 1,219 | 969 | 636.78 |
Earnings From Continuing Operations | 4,011 | 4,067 | 3,367 | 2,661 | 1,628 |
Net Income to Company | 4,011 | 4,067 | 3,367 | 2,661 | 1,628 |
Minority Interest in Earnings | - | - | - | - | 19.44 |
Net Income | 4,011 | 4,067 | 3,367 | 2,661 | 1,648 |
Net Income to Common | 4,011 | 4,067 | 3,367 | 2,661 | 1,648 |
Net Income Growth | -1.38% | 20.79% | 26.53% | 61.51% | 10.28% |
Shares Outstanding (Basic) | 240 | 237 | 222 | 221 | 220 |
Shares Outstanding (Diluted) | 241 | 239 | 223 | 222 | 221 |
Shares Change (YoY) | 1.02% | 6.93% | 0.54% | 0.70% | 5.64% |
EPS (Basic) | 16.72 | 17.15 | 15.19 | 12.03 | 7.51 |
EPS (Diluted) | 16.62 | 17.02 | 15.07 | 11.97 | 7.46 |
EPS Growth | -2.35% | 12.94% | 25.90% | 60.46% | 41.50% |
Free Cash Flow | 6,065 | 4,119 | 4,970 | 1,114 | 2,723 |
Free Cash Flow Per Share | 25.13 | 17.24 | 22.24 | 5.01 | 12.34 |
Dividend Per Share | 2.250 | 2.000 | - | - | - |
Dividend Growth | 12.50% | - | - | - | - |
Gross Margin | 97.78% | 97.80% | 97.73% | 98.21% | 98.05% |
Operating Margin | 14.16% | 15.99% | 16.79% | 14.58% | 15.23% |
Profit Margin | 11.43% | 14.32% | 13.00% | 11.54% | 9.90% |
Free Cash Flow Margin | 17.28% | 14.51% | 19.19% | 4.83% | 16.36% |
EBITDA | 5,869 | 5,069 | 4,853 | 3,735 | 2,729 |
EBITDA Margin | 16.72% | 17.85% | 18.74% | 16.20% | 16.39% |
D&A For EBITDA | 899 | 528 | 506 | 372 | 193.82 |
EBIT | 4,970 | 4,541 | 4,347 | 3,363 | 2,535 |
EBIT Margin | 14.16% | 15.99% | 16.79% | 14.58% | 15.23% |
Effective Tax Rate | 23.60% | 24.59% | 26.58% | 26.69% | 28.11% |
Revenue as Reported | 35,825 | 29,465 | 26,659 | 23,641 | 16,905 |